Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
Go back to Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development| (NASDAQ: NKTX) | Delayed: 2.30 -0.11 (4.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.41 | 52 Week High | $ | |||
| Open | $2.39 | 52 Week Low | $ | |||
| Day High | $2.40 | P/E | N/A | |||
| Day Low | $2.27 | EPS | $ | |||
| Volume | 944,986 | |||||

